已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients

医学 蛛网膜下腔出血 临床终点 改良兰金量表 脑血管痉挛 血管痉挛 尼莫地平 人口 随机对照试验 冲程(发动机) 安慰剂 血管内卷取 麻醉 内科学
作者
Hidenori Endo,Yasushi Hagihara,Naoto Kimura,Katsumi Takizawa,Kuniyasu Niizuma,Osamu Togo,Teiji Tominaga
出处
期刊:Journal of Neurosurgery [Journal of Neurosurgery Publishing Group]
卷期号:: 1-11
标识
DOI:10.3171/2022.2.jns212914
摘要

OBJECTIVE Clazosentan has been investigated globally for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). The authors evaluated its effects on vasospasm-related morbidity and all-cause mortality following aSAH in Japanese patients. METHODS Two similar double-blind, placebo-controlled phase 3 studies were conducted in 57 Japanese centers in patients with aSAH, after aneurysms were secured by endovascular coiling in one study and surgical clipping in the other. In each study, patients were randomly administered intravenous clazosentan (10 mg/hr) or placebo (1:1) starting within 48 hours of aSAH and for up to 15 days after aSAH. Stratified randomization based on World Federation of Neurosurgical Societies grade was performed using a centralized interactive web response system. Vasospasm-related morbidity and all-cause mortality within 6 weeks post-aSAH, including new cerebral infarcts and delayed ischemic neurological deficits as well as all-cause mortality, were the first primary endpoint in each study. The second primary endpoint was all-cause morbidity (new cerebral infarct or delayed ischemic neurological deficit from any causes) and all-cause mortality (all-cause morbidity/mortality) within 6 weeks post-aSAH. The incidence of individual components of the primary morbidity/mortality endpoints within 6 weeks and patient outcome at 12 weeks post-aSAH (including the modified Rankin Scale scores) were also evaluated. The above analyses were also performed in the population pooled from both studies. RESULTS In each study, 221 patients were randomized and 220 were included in the full analysis set of the primary analysis (109 in each clazosentan group, 111 in each placebo group). Clazosentan significantly reduced the incidence of vasospasm-related morbidity and all-cause mortality after aneurysm coiling (from 28.8% to 13.6%; relative risk reduction 53%; 95% CI 17%–73%) and after clipping (from 39.6% to 16.2%; relative risk reduction 59%; 95% CI 33%–75%). All-cause morbidity/mortality and poor outcome (dichotomized modified Rankin Scale scores) were significantly reduced by clazosentan after preplanned study pooling. Treatment-emergent adverse events were similar to those reported previously. CONCLUSIONS Clazosentan significantly reduced the combined incidence of vasospasm-related morbidity and all-cause mortality post-aSAH with no unexpected safety findings. Clinical trial registration nos.: JapicCTI-163368 and JapicCTI-163369 ( https://www.clinicaltrials.jp )
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
超级小熊猫完成签到 ,获得积分10
刚刚
SS完成签到,获得积分0
2秒前
慕青应助科研通管家采纳,获得10
3秒前
酷波er应助科研通管家采纳,获得30
3秒前
双黄应助科研通管家采纳,获得10
3秒前
丘比特应助科研通管家采纳,获得10
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
sugarballer完成签到 ,获得积分10
4秒前
几米完成签到 ,获得积分10
5秒前
jessie完成签到 ,获得积分10
8秒前
洪荒爆发完成签到,获得积分10
9秒前
essemmy发布了新的文献求助10
11秒前
13秒前
天真的皓轩完成签到,获得积分10
13秒前
宋潮完成签到,获得积分10
17秒前
18秒前
鳗鱼谷丝完成签到 ,获得积分10
20秒前
shelemi发布了新的文献求助10
20秒前
宇宇完成签到 ,获得积分10
21秒前
莫惊春睡完成签到,获得积分20
21秒前
图图完成签到 ,获得积分10
25秒前
忧虑的羊完成签到 ,获得积分20
25秒前
叩桥不渡完成签到,获得积分10
28秒前
chen完成签到 ,获得积分0
29秒前
31秒前
Jane完成签到 ,获得积分10
31秒前
汉堡包应助fengyuke采纳,获得10
32秒前
34秒前
liuchenyang完成签到 ,获得积分10
34秒前
Billy发布了新的文献求助10
35秒前
高贵逍遥完成签到 ,获得积分10
36秒前
36秒前
马爱林发布了新的文献求助10
37秒前
科目三应助然然采纳,获得10
38秒前
39秒前
乐乐应助神勇雨双采纳,获得10
39秒前
ryanfeng完成签到,获得积分10
40秒前
43秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 890
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3256743
求助须知:如何正确求助?哪些是违规求助? 2898891
关于积分的说明 8302965
捐赠科研通 2568062
什么是DOI,文献DOI怎么找? 1394872
科研通“疑难数据库(出版商)”最低求助积分说明 652924
邀请新用户注册赠送积分活动 630631